Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Graft-versus-host disease | R-HSA-1643685 | map05332 | eticlopride | 4993 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | eticlopride | 4993 | drug-path |
Wnt signaling pathway | R-HSA-195721 | map04310 | eticlopride | 4993 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | eticlopride | 4993 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | eticlopride | 4993 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | eticlopride | 4993 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | eticlopride | 4993 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | eticlopride | 4993 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | eticlopride | 4993 | drug-path |
Vibrio cholerae infection | R-HSA-9609646 | map05110 | eticlopride | 4993 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | eticlopride | 4993 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | eticlopride | 4993 | drug-path |
Melanogenesis | R-HSA-5662702 | map04916 | eticlopride | 4993 | drug-path |
Glioma | Q9NZM4 | map05214 | eticlopride | 4993 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | eticlopride | 4993 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | eticlopride | 4993 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | eticlopride | 4993 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | eticlopride | 4993 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | eticlopride | 4993 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | eticlopride | 4993 | drug-path |